ENTA icon

Enanta Pharmaceuticals
ENTA

Overview Fund Activity

126 hedge funds and large institutions have $396M invested in Enanta Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 46 increasing their positions, 48 reducing their positions, and 32 closing their positions.

Holders
126
Holders Change
-23
Holders Change %
-15.44%
% of All Funds
3.14%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
16
Increased
46
Reduced
48
Closed
32
Calls
$412K
Puts
$1.79M
Net Calls
-$1.38M
Net Calls Change
-$1.87M

Top Buyers

1
BlackRock
1
BlackRock
New York
$70.7M
2
First Manhattan
2
First Manhattan
New York
$27.1M
3
Millennium Management
3
Millennium Management
New York
$13.6M
4
GTC
4
Ghost Tree Capital
New York
$9.24M
5
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$12.7M

Top Sellers

1
GPP
1
Great Point Partners
Connecticut
$0
2
Acadian Asset Management
2
Acadian Asset Management
Massachusetts
$8.07M
3
GIM
3
Granahan Investment Management
Massachusetts
$6.08M
4
AL
4
AJO LP
Pennsylvania
$0
5
SCP
5
Seizert Capital Partners
Michigan
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
FCM
151
Flinton Capital Management
Pennsylvania
– -$11K -320 Closed
EF
152
Empirical Finance
Pennsylvania
– -$5K -123 Closed
FAN
153
Financial Advisors Network
California
– -$3.8K -117 Closed
IUHSA
154
Itau Unibanco Holding S.A.
Brazil
– -$4K -110 Closed
AF
155
Allworth Financial
California
– -$3K -100 Closed
BBHC
156
Brown Brothers Harriman & Co
New York
– -$3K -93 Closed
3 4 5 6
7